Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Decker, T.; Brucker, C.; Fasching, P. et al.
Treatment of elderly patients (pts; > 75 years) with 1st-line ribociclib (RIB) plus endocrine therapy (ET) or endocrine monotherapy in clinical routine: Real-world data from the RIBANNA study (5th interim analysis (IA))ANNALS OF ONCOLOGY. Bd. 34. 2023 S. S354-S355
Roser, Eva; Harter, Philipp; Zocholl, Dario et al.
Treatment strategies in patients with gynecological sarcoma: Results of the prospective intergroup real-world registry for gynecological sarcoma in Germany (REGSA-NOGGO RU1)INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2023
Battista, Marco Johannes; Anic, Katharina; Linz, Valerie et al.
Two-step frailty assessment algorithm for women with various gynecological malignancies-results of an interim-analysis of a prospective observational cohort studyZEITSCHRIFT FUR GERONTOLOGIE UND GERIATRIE. Bd. 56. 2023 S. S3-S3
Weimer, Johannes; Dionysopoulou, Anna; Strelow, Kai-Uwe et al.
Undergraduate ultrasound training: prospective comparison of two different peer assisted course models on national standardsBMC MEDICAL EDUCATION. Bd. 23. H. 1. 2023
Bartlett, John M. S.; Xu, Keying; Wong, Jenna et al.
Validation of the Breast Cancer Index (BCI) prognostic models optimized for late distant recurrence in postmenopausal women with early-stage HR plus breast cancer in the TEAM trialCANCER RESEARCH. Bd. 83. H. 5. 2023
Kowalewski, Karl-Friedrich; Seifert, Laura; Kohlhas, Laura et al.
Video-based training of situation awareness enhances minimally invasive surgical performance: a randomized controlled trialSURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES. Bd. 37. H. 6. 2023 S. 4962-4973
Schmidt, Marcus
Which Patients Need Chemotherapy? From Pathological Risk Factors to Gene Signatures and Evaluation of Endocrine ResponseBREAST CARE. 2023
Rohner, Annika; Grube, Marcel; Knoll, Katharina et al.
A CURRENT PERSPECTIVE ON ENDOMETRIAL CARCINOMA (EC) RISK CLASSIFICATION: RESULTS FROM AN EUROPEAN MULTICENTRE INITIATIVEINTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. Bd. 32. 2022 S. A35-A35
Schmidt, M.; Luebbe, K.; Decker, T. et al.
A multicentre, randomised, double-blind, phase II study to evaluate the tolerability of an induction dose escalation of everolimus in patients with metastatic breast cancer (DESIREE)ESMO OPEN. Bd. 7. H. 6. 2022
Baaken, Dan; Merzenich, Hiltrud; Schmidt, Marcus et al.
A nested case-control study on radiation dose-response for cardiac events in breast cancer patients in GermanyBREAST. Bd. 65. 2022 S. 1-7